Related references
Note: Only part of the references are listed.Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero
Jessica Lidstrom et al.
AIDS (2010)
Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor-Based Viral Suppression A Randomized Controlled Trial
Ashraf Coovadia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
Charles S. Chasela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure
Paul Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Short Communication: In Utero HIV Infection Is Associated with an Increased Risk of Nevirapine Resistance in Ugandan Infants Who Were Exposed to Perinatal Single Dose Nevirapine
Jessica D. Church et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
Anitha Moorthy et al.
PLOS ONE (2009)
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission
Jessica D. Church et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials
LANCET (2008)
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants.
Avy Violari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission
Newton I. Kumwenda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine
Neil A. Martinson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Response to antiretroviral therapy after a single, peripartum dose of nevirapine
Shahin Lockman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine - HIVNET 012
SH Eshleman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N Nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012
T Flys et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP
SH Eshleman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
LigAmp for sensitive detection of single-nucleotide differences
CJ Shi et al.
NATURE METHODS (2004)
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
SH Eshleman et al.
AIDS (2001)
Share Paper
